
GEMMABio
GEMMABio, a new therapeutics company, will serve as the research and innovation arm to speed the research of and global access to life-changing advanced therapies for those living with rare diseases.
$34M Seed ·
Source: fundraisingfox.com
Funding history ↓Signals
Website registeredMay 10, 2022 (4 years old)
Funding rounds
- Seed · $34MSource: fundraisingfox.com
- Website created
Companies like GEMMABio
PPulseSight TherapeuticsSeries A · Feb 2025QQubit PharmaceuticalsSeed · Jun 2022
VVaderis Therapeutics$152M Series B+ · Aug 2026
AAddition Therapeutics$100M Series A · Dec 2025
HHotSpot Therapeutics$100M Series B+ · Nov 2021
EEvolyra TherapeuticsSeed · Apr 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/gemmabio (get a free API key).